¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

Á¦16ȸ °©»ó¼±¿¬¼öȸ : 2019-06-15

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
Á¦16ȸ °©»ó¼±¿¬¼öȸ : 2019-06-15
±³À°ÀÏÀÚ : 2019-06-15
±³À°Àå¼Ò : ÇѾç´ëÇб³ HIT 6Ãþ ´ë°­´ç  
±³À°ÁÖÁ¦ : Á¦16ȸ °©»ó¼±¿¬¼öȸ
ÁÖÃÖ±â°ü : ´ëÇѵΰæºÎ¿Ü°úÇÐȸ
´ã´çÀÚ : À̽¾Æ
¿¬¶ôó : 070-4108-7957  
À̸ÞÀÏ : ksthns1990@gmail.com      
±³À°Á¾·ù : À̺ñÀÎÈÄ°ú      
Âü¼®¿¹»óÀοø : 100¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 7 ½Ã°£ 30ºÐ  
¼¼ºÎ¼ö°­·á : 50,000¿ø      
ºñ°í Àü¹®ÀÇ »çÀüµî·Ï 4¸¸¿ø ÇöÀåµî·Ï 5¸¸¿ø Àü°øÀÇ »çÀüµî·Ï 3¸¸¿ø ÇöÀåµî·Ï 4¸¸¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 06-15 ´ë°­´ç 08:00~08:20 Registration  () 
±âŸ 06-15 ´ë°­´ç 08:20~08:30 Opening Remark  Å°æ(ÇѾçÀÇ´ë) 
±³À°½Ã°£ 06-15 ´ë°­´ç 08:30~08:45 Thyroid Cancer Epidemiology and Screening  ¼Ûâ¸é(ÇѾçÀÇ´ë) 
±³À°½Ã°£ 06-15 ´ë°­´ç 08:45~09:00 The New Bethesda System 2017 - What are the Changes?  ½Å¼öÁø(ÇѾçÀÇ´ë º´¸®°ú) 
±³À°½Ã°£ 06-15 ´ë°­´ç 09:00~09:15 Molecular Analysis of Thyroid Nodule  ÁÖ¿µÈÆ(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 06-15 ´ë°­´ç 09:15~09:30 Ultrasonographic Risk Stratification of Thyroid Nodule  ±èÁ¤±Ô(´ë±¸°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 06-15 ´ë°­´ç 09:30~09:45 AJCC staging of thyroid cancer: What are the changes?  ±èÇѼö(ÀÌÈ­ÀÇ´ë) 
±³À°½Ã°£ 06-15 ´ë°­´ç 09:45~10:00 International Guidelines: Primary thyroid surgery for DTC  À̱¹Çà(¿øÀÚ·ÂÀÇÇпø) 
±³À°½Ã°£ 06-15 ´ë°­´ç 10:00~10:15 Active surveillance of PTC: Where are we standing?  ¿ìÁ¤¼ö(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 06-15 ´ë°­´ç 10:15~10:30 Transoral Vestibular Approach Thyroid and Parathyroid Surgery: The Promise and Value of Leaving No Trace  Ralph P. Tufano(USA) 
È޽Ġ06-15 ´ë°­´ç 10:30~10:45 coffee break  () 
±³À°½Ã°£ 06-15 ´ë°­´ç 10:45~11:15 Management of Neck in PTC: From Controversy to Consensus  Sefik Hosal(Turkey) 
±³À°½Ã°£ 06-15 ´ë°­´ç 11:15~11:30 IONM in Thyroid Surgury: Basics and New Guidelines  Áö¿ë¹è(ÇѾçÀÇ´ë) 
±³À°½Ã°£ 06-15 ´ë°­´ç 11:30~11:40 Non-endotracheal tube based IONM with the needle or skin adhesive electrode  ÀÌ°­´ë(°í½ÅÀÇ´ë) 
±³À°½Ã°£ 06-15 ´ë°­´ç 11:40~11:55 Parathyroid Identification and Preservation with Auto-fluorescence  ±è¼º¿ø(°í½ÅÀÇ´ë) 
±³À°½Ã°£ 06-15 ´ë°­´ç 11:55~12:10 Management of Invasion and Injury of the RLN: Improvement of voice  À̽¿ø(¼øõÇâÀÇ´ë) 
±³À°½Ã°£ 06-15 ´ë°­´ç 12:10~12:25 Management of Postthyroidetomy Hypocalcemia and Hypoparathyroidism  ±¸º»¼®(Ãæ³²ÀÇ´ë) 
½Ä»ç 06-15 ´ë°­´ç 12:25~13:25 lunch  () 
±³À°½Ã°£ 06-15 ´ë°­´ç 13:25~13:55 Forecasting the Next Edition of the ATA Guidelines for the Management of Thyroid Nodules and Differentiated Thyroid Cancer  Ralph P. Tufano(USA) 
±³À°½Ã°£ 06-15 ´ë°­´ç 13:55~14:10 Surgical Management of Areodigestive Tract Invasion  ±èöȣ(¾ÆÁÖÀÇ´ë) 
±³À°½Ã°£ 06-15 ´ë°­´ç 14:10~14:30 RAI Ablation: Who, Why, When and How?  ±èÁö¿µ(ÇѾçÀÇ´ë ÇÙÀÇÇаú) 
±³À°½Ã°£ 06-15 ´ë°­´ç 14:30~14:45 Long-term Follow-up of DTC patients: Which tests? How often? How long?  ÀÓâÈÆ(Á¦ÀϺ´¿ø ³»ºÐºñ³»°ú) 
±³À°½Ã°£ 06-15 ´ë°­´ç 14:45~15:00 Management of Loco-regional Recurrent Cancer  ¹é½Â±¹(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 06-15 ´ë°­´ç 15:00~15:15 Systemic Therapy for Refractory or Metastatic Thyroid Cancer  °íÀ±¿ì(¿¬¼¼ÀÇ´ë) 
È޽Ġ06-15 ´ë°­´ç 15:15~15:30 coffee break  () 
±³À°½Ã°£ 06-15 ´ë°­´ç 15:30~15:45 The role of multidisciplinary team in the management of thyroid cancer  Sefik Hosal(Turkey) 
±³À°½Ã°£ 06-15 ´ë°­´ç 15:45~16:00 Management of Follicular Neoplasm and Cancer  À̼¼¿µ(Áß¾ÓÀÇ´ë) 
±³À°½Ã°£ 06-15 ´ë°­´ç 16:00~16:15 Diagnosis and RET mutation of MTC  ¹ÚÀϼ®(ÇѸ²ÀÇ´ë) 
±³À°½Ã°£ 06-15 ´ë°­´ç 16:15~16:30 Surgical Management of MTC  Á¤¿µÈ£(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 06-15 ´ë°­´ç 16:30~16:45 Management of Anaplastic carcinoma  À̺´ÁÖ(ºÎ»êÀÇ´ë) 
±³À°½Ã°£ 06-15 ´ë°­´ç 16:45~17:30 Case presentor  ÀÌÇü½Å(°í½ÅÀÇ´ë) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" Á¦16ȸ °©»ó¼±¿¬¼öȸ : 2019-06-15""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇÑÈäºÎ¿Ü°úÇÐȸ 2019³â Á¦6ȸ ÃÊÀ½ÆÄ ¿¬¼ö°­Á : 2019-06-15
´ÙÀ½±Û 2019³â ´ëÇѳëÀκ´ÇÐȸ Á¦63Â÷ Çмú´ëȸ(Ãá°è) : 2019-06-15
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20910 ¼­¿ï 2024³â Á¦14ȸ °¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ³»ºÐºñ³»°ú ¿¬¼ö°­Á : 2024-07-07 0 2 2024-05-28
20909 °æ±â ¾ÆÁÖ´ëÇб³º´¿ø Á¤Çü¿Ü°ú 30Áֳ⠱â³ä ½ÉÆ÷Áö¿ò : 2024-07-07 0 6 2024-05-28
20908 ¼­¿ï Á¦19Â÷ ´ëÇѸðÀ¯¼öÀ¯ÀÇÇÐȸ Ãá°èÇмú´ëȸ : 2024-07-07 0 4 2024-05-28
20907 °æ±â Á¦2Â÷ ´ëÇѽŰæ¹æ»ç¼±¼ö¼úÇÐȸ Á¤±âÇмú´ëȸ : 2024-07-06 0 2 2024-05-28
20906 °æ±â Á¦ 5ȸ ¿À»ê½ÃÀÇ»çȸ Çмú´ëȸ : 2024-07-06 0 2 2024-05-28
20905 ¼­¿ï ¼­¿ï¾Æ»êº´¿ø Á¦3ȸ ¾Æ»êµÎ°æºÎ Æ÷·³ : 2024-07-06 0 1 2024-05-28
20904 ¼­¿ï 2024³â Á¦2ȸ °¡Å縯´ëÇб³ ÀºÆò¼º¸ðº´¿ø ¼øȯ±â³»°ú °³¿øÀÇ ¿¬¼ö°­Á : 2024-07-06 0 6 2024-05-28
20903 ¼­¿ï ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ENDO 2024 (Day3) : 2024-07-06 0 2 2024-05-28
20902 ¼­¿ï ´ëÇѽŰæÁýÁßÄ¡·áÇÐȸ 2024³â ÇÏ°è NeurocrItical Care Essence (NICE) ¾ÆÄ«µ¥¹Ì : 2024-07-06 0 1 2024-05-28
20901 ¼­¿ï ¼­¿ï´ëÇб³º´¿ø Á¦10ȸ ºÎ½Å¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2024-07-06 0 1 2024-05-28
20900 ¼­¿ï ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ENDO 2024 (Day2) : 2024-07-05 0 1 2024-05-28
20899 ¼­¿ï ÀÓ»ó¼ú±â±³À°¿¬±¸È¸ Á¦16ȸ ÀÓ»ó¼ú±â ¿¬¼ö°­Á : 2024-07-04 0 2 2024-05-28
20898 °æ±â ¿ëÀμ¼ºê¶õ½ºº´¿ø µðÁöÅÐÀÇ·á½ÉÆ÷Áö¾ö -¹Ì·¡ ÀǷḦ À§ÇÑ ±³·ù¿Í Çù·Â : 2024-07-04 0 1 2024-05-28
20897 ¼­¿ï ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ENDO 2024 (Day1) : 2024-07-04 0 0 2024-05-28
20896 ¼­¿ï ´ëÇÑ»êºÎÀΰúÇÐȸ ¼­ºÎÁöȸ Á¤±â Áý´ãȸ(Àڱ󻸷Áõ½ÄÁõ) : 2024-07-02 0 0 2024-05-28
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷